| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 111.78B | 115.68B | 111.55B | 128.19B | 120.52B | 114.00B |
| Gross Profit | 24.01B | 26.46B | 23.31B | 22.07B | 19.74B | 19.01B |
| EBITDA | 10.57B | 11.43B | 10.12B | 9.83B | 8.41B | 7.64B |
| Net Income | 4.94B | 5.85B | 4.54B | 4.46B | 3.43B | 3.33B |
Balance Sheet | ||||||
| Total Assets | 102.55B | 122.54B | 107.07B | 107.04B | 108.98B | 107.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.19B | 10.61B | 3.09B | 1.14B | 1.27B | 10.29B |
| Total Debt | 628.00M | 2.91B | 669.00M | 2.60B | 2.25B | 2.11B |
| Total Liabilities | 35.91B | 46.85B | 40.79B | 44.06B | 49.88B | 48.32B |
| Stockholders Equity | 66.63B | 71.28B | 66.28B | 62.98B | 59.10B | 59.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.20B | 5.43B | -1.19B | 110.00M | 6.00B |
| Operating Cash Flow | 0.00 | 10.66B | 8.78B | 2.06B | 2.95B | 9.10B |
| Investing Cash Flow | 0.00 | -489.00M | -3.28B | -4.80B | -4.75B | -2.61B |
| Financing Cash Flow | 0.00 | -2.82B | -3.56B | -894.00M | -3.73B | -3.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
76 Outperform | ¥14.51B | 8.19 | ― | 3.03% | 6.36% | 41.53% | |
73 Outperform | ¥51.00B | 10.00 | ― | 4.09% | 3.70% | 29.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | ¥36.28B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
51 Neutral | ¥392.48B | 17.81 | ― | 3.62% | 16.26% | -52.33% |